AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglam GM 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Alde Medi Impex Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Voglam GM 2mg/500mg/0.2mg Tablet SR

Diabetics utilizing Voglam GM 2mg/500mg/0.2mg SR tablets, an anti-diabetic medication combination, manage type 2 diabetes mellitus. This formulation helps regulate blood glucose in adults. Administer Voglam GM with meals, consistently at the same time daily for optimal efficacy. Dosage, determined by your physician, may adjust based on blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially causing kidney impairment, vision loss, neuropathy, and limb complications. This medication complements a comprehensive diabetes management plan, including diet, exercise, and weight management as recommended by your doctor. Commonly, Voglam GM can cause hypoglycemia (low blood sugar). Learn to recognize hypoglycemia symptoms—sweating, dizziness, headache, trembling—and have readily available glucose, like sugary snacks or juice. Alcohol increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease, Voglam GM requires prior consultation with your physician if you have a history of heart disease. Pregnant or breastfeeding individuals must also seek medical advice before use. Regular blood glucose monitoring and potential blood tests (blood counts, liver function) will be necessary as directed by your doctor.

Uses of Voglam GM 2mg/500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Voglam GM 2mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Voglam GM 2mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or fracture it. Consume it on an empty stomach.

Common Side effects of Voglam GM 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglam GM 2mg/500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglam GM 2mg/500mg/0.2mg Extended-Release tablets should be administered on an empty stomach.

How Voglam GM 2mg/500mg/0.2mg Tablet SR works:

Voglam GM SR tablets (2mg/500mg/0.2mg) combine three antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Voglam GM 2mg/500mg/0.2mg SR tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Voglam GM 2mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Voglam GM 2mg/500mg/0.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Operating a vehicle could be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Voglam GM 2mg/500mg/0.2mg Tablet SR, as its use may be unsafe. A physician's consultation is advised. The use of Voglam GM 2mg/500mg/0.2mg Tablet SR is contraindicated in those with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Voglam GM 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Voglam GM 2mg/500mg/0.2mg Tablet SR :

Should you forget to take a Voglam GM 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglam GM 2mg/500mg/0.2mg Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Voglam GM 2mg/500mg/0.2mg Tablet SR

Voglam GM 2mg/500mg/0.2mg Extended-Release tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas. Metformin reduces hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal glucose levels. This formulation is unsuitable for type 1 diabetes.
Taking Voglam GM 2mg/500mg/0.2mg SR tablets may cause common side effects including low blood sugar, nausea, diarrhea, taste changes, gas, abdominal pain, headache, skin rash, and respiratory infections.
Patients with hypersensitivity to any constituent of Voglam GM 2mg/500mg/0.2mg Tablet SR should not receive this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis, such as diabetic ketoacidosis.
Combining Voglam GM 2mg/500mg/0.2mg SR tablets with alcohol is unsafe. This combination risks lowering blood glucose to dangerous levels (hypoglycemia) and elevates the likelihood of lactic acidosis.
Indeed, taking Voglam GM 2mg/500mg/0.2mg SR tablets may lead to hypoglycemia (low blood glucose). Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, a rapid pulse, and feelings of anxiety or trembling. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concurrent use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. It's advisable to keep readily available sources of glucose, such as glucose tablets, honey, or fruit juice, on hand.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Voglam GM 2mg/500mg/0.2mg...
80
MRP 97
17% off